Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey

International Journal of Antimicrobial Agents

Volumn 36, Issue 2, 2010, Pages 114-118

  Kulah, Canan ^a   Mooij, Marlies J ^b   Comert, Fusun ^a   Aktas, Elif ^a   Celebi, Guven ^c   Ozlu, Nagihan ^a   Rijnsburger, Martine C ^b   Savelkoul, Paul H M ^b  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; BlaOXA 58; Carbapenems; Outbreak; OXA 58; Oxacillinase

Indexed keywords

CARBAPENEM; METALLO BETA LACTAMASE; OLIGONUCLEOTIDE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; FEMALE; GENETIC ANALYSIS; GIM 1 GENE; HUMAN; IMP 1 GENE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONHUMAN; OXA 23 LIKE GENE; OXA 24 LIKE GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SIM 1 GENE; SPM 1 GENE; TURKEY (REPUBLIC); VIM LIKE GENE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CHILD; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HOSPITALS, UNIVERSITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; TURKEY;

EID: 77953808567     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.03.017     Document Type: Article

References (23)

1. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
2. Dalla-Costa L.M., Coelho J.M., Souza H.A., Castro M.E., Stier C.J., Bragagnolo K.L., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003, 41:3403-3406.
3. Héritier C., Dubouix A., Poirel L., Marty N., Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother 2005, 55:115-118.
4. Pournaras S., Markogiannakis A., Ikonomidis A., Kondyli L., Bethimouti K., Maniatis A.N., et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J Antimicrob Chemother 2006, 57:557-561.
5. Poirel L., Lebessi E., Héritier C., Patsoura A., Foustoukou M., Nordmann P. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece. Clin Microbiol Infect 2006, 12:1138-1141.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard. 10th ed. Document M02-A10. Wayne, PA: CLSI; 2009.
8. Savelkoul P.H.M., Aarts H.J.M., de Haas J., Dijkshoorn L., Duim B., Otsen M., et al. Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 1999, 37:3083-3091.
9. Koeleman J.G.M., Stoof J., Biesmans D.J., Sabelkoul P.H.M., Vandenbroucke-Grauls C.M. Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii. J Clin Microbiol 1998, 36:2522-2529.
10. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
11. Mendes R.E., Kiyota K.A., Monteiro J., Castanheira M., Andrade S.S., Gales A.C., et al. Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 2007, 45:544-547.
12. Brown S., Young H.K., Amyes S.G.B. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005, 11:15-23.
13. Coelho J.M., Turton J.F., Kaufmann M.E., Glover J., Woodford N., Warner M., et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006, 44:3623-3627.
14. Coelho J., Woodford N., Afzal-Shah M., Livermore D. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 2006, 50:756-758.
15. Bogaerts P., Naas T., Wybo I., Bauraing C., Soetens O., Piérard D., et al. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J Clin Microbiol 2006, 44:4189-4192.
16. Zarrilli R., Casillo R., Di Popolo A., Tripodi M.F., Bagattini M., Cuccurullo S., et al. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clin Microbiol Infect 2007, 13:481-489.
17. Marque S., Poirel L., Heriteir C., Brisse S., Blasco M.D., Filip R., et al. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 2005, 43:4885-4888.
18. Vahaboglu H., Budak F., Kasap M., Gacar G., Torol S., Karadenizli A., et al. High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother 2006, 58:537-542.
19. Gur D., Korten V., Unal S., Deshpande L.M., Castanheira M. Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites. J Med Microbiol 2008, 57:1529-1532.
20. van Dessel H., Dijkshoorn L., van der Reijden T., Bakker N., Paauw A., van den Broek, et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 2004, 155:105-112.
21. Hanlon G.W. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol 2005, 41:375-378.
22. Turton J.F., Kaufmann M.E., Warner M., Coelho J., Dijkshoorn L., van der Reijden T., et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 2004, 58:170-179.
23. Urban C., Segal-Maurer S., Rahal J.J. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003, 36:1268-1274.